DC Field | Value | Language |
dc.contributor.author | Timercan, Tatiana | |
dc.date.accessioned | 2019-04-16T12:17:03Z | |
dc.date.available | 2019-04-16T12:17:03Z | |
dc.date.issued | 2018 | |
dc.identifier.citation | TIMERCAN, Tatiana. A modern approach to interleukin-6. In: The Moldovan Medical Journal. 2018, vol. 61, no 3, pp. 47-52. ISSN 2537-6373. | en_US |
dc.identifier.issn | 2537-6373 | |
dc.identifier.issn | 2537-6381 | |
dc.identifier.uri | http://repository.usmf.md/handle/20.500.12710/1216 | |
dc.identifier.uri | https://doi.org/10.5281/zenodo.1299041 | |
dc.identifier.uri | http://moldmedjournal.md/wp-content/uploads/2019/01/moldmedjournal-2018-61-3-full-issue.pdf | |
dc.description | Department of Biochemistry and Clinical Biochemistry, Nicolae Testemitsanu State University of Medicine and Pharmacy, Chisinau, the Republic of Moldova | en_US |
dc.description.abstract | Background: Interleukin-6 is a multifunctional cytokine with well-defined pro- and anti-inflammatory properties. Binding to the receptor complex
composed of specific interleukin-6-receptor (IL-6R) and transmembrane glycoprotein gp130, it stimulates various signalling cascades. Intracellular
signal transduction involves both STAT-dependent, and STAT-independent mechanisms. IL-6R exists in the soluble and the membrane-bound forms,
thus were described the classical signalling and the trans-signalling pathways. The pro-inflammatory response occurs via trans-signalling, while the antiinflammatory effects are mediated by classical signalling pathway. IL-6 is produced by cardiovascular components. The high levels of IL-6 are identified
in the inflammatory diseases.
Conclusions: IL-6 expresses the well-defined pro- and anti-inflammatory properties. The experimental studies have revealed classic signalling pathway
with regenerative and anti-inflammatory effects (via the membrane-bound IL-6R), and trans-signalling responsible for the pro-inflammatory response
(via the soluble form sIL-6R). The intracellular signal transduction involves the activation of STATs, MAPK, and PI3K cascades. It has been proved that
in the cardiovascular pathologies the serum levels of IL-6 correlate with the disease severity and the degree of myocardial damage, being the indicator of
heart disease and a predictive factor of adverse outcomes. | en_US |
dc.language.iso | en | en_US |
dc.publisher | The Scientific Medical Association of the Republic of Moldova | en_US |
dc.relation.ispartof | The Moldovan Medical Journal | |
dc.subject | interleukin-6 | en_US |
dc.subject | cytokine | en_US |
dc.subject | trans-signalling | en_US |
dc.subject | cardiac ischemia | en_US |
dc.subject.ddc | UDC: 577.112.6 | |
dc.subject.mesh | Interleukin-6 | en_US |
dc.subject.mesh | Cytokines | en_US |
dc.subject.mesh | Cell Differentiation | en_US |
dc.subject.mesh | Cell Proliferation | en_US |
dc.subject.mesh | Cell Movement | en_US |
dc.subject.mesh | Apoptosis | en_US |
dc.subject.mesh | Glycoproteins | en_US |
dc.title | A modern approach to interleukin-6 | en_US |
dc.type | Article | en_US |
Appears in Collections: | The Moldovan Medical Journal, Vol. 61, No 3, October 2018
|